Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Kane Biotech Inc
KNBIF
Primary Symbol:
V.KNE
Healthcare
Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired...
from research institutions. DispersinB, coactiv+, coactiv+, DermaKB, DermaKB Biofilm, and revive are trademarks of the Company. Its patented coactiv+ technology is specifically formulated to destabilize biofilm and create an environment for fast wound healing. In Wound Care & Surgical applications, in addition to revyve Antimicrobial Wound Gel, it is developing follow-on products with three applications: coactiv+ Antimicrobial Surgical Hydrogel, coactiv+ Antimicrobial Wound Gel Spray, and coactiv+ Antimicrobial Wound Rinse. The Company's other biofilm disruption technology is DispersinB.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:KNE)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 14, 2024 1:10pm
New Press Release - Kane Biotech Announces Health Canada Approval of revyve(TM) Antimicrobial Wound Gel
WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has received Health Canada approval of its revyve™ Antimicrobial Wound Gel as a Class 2 Medical Device.This approval allows the Company to...
read article.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 14, 2024 9:54am
RE:New Press Release - Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement
The video is helping with answering questions investors might have, not all questions are being answered but some, here's the key points -- feel free to add or comments on those if you see it
...more
Lahontan Gold Announces Filing of Santa Fe Technical Report
posted Nov 29, 2024 9:00am by
Lahontan Gold Corp.
-
|
Lahontan Gold is pleased to announce that the Company has filed on SEDAR+ an independent Technical Report and updated Mineral Resource Estimate ("MRE") titled "Santa Fe Project Technical Report," effective October 9, 2024, and dated November 27, 2024, for Lahontan's Santa Fe Mine gold and silver project, Santa Fe District, Mineral County, Nevada. ...read more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Nov 14, 2024 8:30am
New Press Release - Kane Biotech Provides Investor Update Following FB Dermatology Acquisition Announcement
President & CEO Marc Edwards and Executive Chair Dr. Robert Huizinga Discuss This Strategic Opportunity WINNIPEG, Manitoba, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company”, “Kane Biotech”) announces today that President & CEO, Marc Edwards and Dr...
read article.
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 13, 2024 10:49pm
RE:RE:RE:RE:RE:Acquistion
Most people figured out that lfs complained about not knowing the revenues. then he switched to complaining that there was no purchase price listed in the next breath. Neither was a valid complaint
...more
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Nov 13, 2024 1:27pm
RE:RE:RE:RE:Acquistion
He is no troll. That was me that posted purchase price, it was at the end of the NR and may have been overlooked. We all overlook things sometimes. On the topic of this acquisition, it looks
...more
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 13, 2024 11:26am
RE:RE:RE:Acquistion
lscfa must be a troll, because you effortlessly switched from complaining about revenues to purchase price.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Nov 12, 2024 11:18pm
RE:RE:RE:RE:Acquistion
Subject to adjustments set out in the Term Sheet, the aggregate purchase price expected to be paid by the Company for the Purchased Shares shall consist of the following: (i) approximately $200,000 in
...more
(2181)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 12, 2024 10:28pm
RE:RE:RE:Acquistion
Should read almost all co.s include in NRs about acquistions some metrics so investors can determine if co paid too much.
(2181)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Nov 12, 2024 10:11pm
RE:RE:Acquistion
Total bs. Almost all co. NRs about acquistions include a purchase price so investors can determine if too much was paid.
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 12, 2024 9:46pm
FLE for the treatment of acute 2nd degree burns
The more I search the more I find interesting study and article about FB/FLE...this one from 'Military Medicine' that goes back to 2021 -- it looks like we are in the early stage of this
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 12, 2024 9:23pm
Fluorescence Biomodulation -- study (2020)
It looks like FB technology is already being use by veterinarians to treat wounds, see link to study from 2019/20; Wound healing using FB - 2019/20 There is a division of Vetoquinol called Phovia that
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Post by
francoisl13
on Nov 12, 2024 9:09pm
LumiHeal evaluation abstract (2018)
Interesting (short) reading for those who wants to know a little more about one of the technology acquired by Kane earlier today; LumiHeal study abstract 2018 GLTA!
(8)
•••
KevinOleary
X
View Profile
View Bullboard History
Comment by
KevinOleary
on Nov 12, 2024 5:31pm
RE:RE:RE:I wonder....
I don't think I was clear enough. Only a mind reader can know what the FDA will do, and you would have to read a bunch of minds because it is very bureaucratic and needs a bunch of people to check
...more
(75)
•••
francoisl13
X
View Profile
View Bullboard History
Comment by
francoisl13
on Nov 12, 2024 5:15pm
RE:RE:I wonder....
Yo kevinOleary, long time no talk... Yup agree... but understanding the fact that we don't have control over the FDA agenda should give KNE management another reason to set the expectations a
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >